MedPath

Potential Beneficial Effects of Resveratrol

Not Applicable
Completed
Conditions
Metabolic Syndrome
Obesity
Interventions
Dietary Supplement: Resveratrol
Other: Placebo
Registration Number
NCT01150955
Lead Sponsor
University of Aarhus
Brief Summary

We want to investigate whether the food supplement resveratrol is able to counteract the detrimental effects of obesity.

Detailed Description

The aim of this study is to investigate potential metabolic effects of resveratrol in healthy but obese men. We hypothesize that resveratrol will counteract some of the detrimental effects of obesity, and as an imitator of calorie restriction will give new insight into the basic biochemical pathways underpinning human metabolism. Of special interest is the potential connection between resveratrol, calorie restriction, SIRT1, STAT5b and the GH/IGF-I axis.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
24
Inclusion Criteria
  • BMI > 30 kg/m2
  • Otherwise healthy
  • Written informed consent
Exclusion Criteria
  • Any disease
  • Alcohol dependency
  • Allergy to trial medication
  • Present or previous malignancy
  • Participation in other clinical trials within three months before randomization

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ResveratrolResveratrolDietary supplement of resveratrol 500 mg three times a day over five weeks.
PlaceboPlacebo-
Primary Outcome Measures
NameTimeMethod
Metabolic parametersFive weeks

Regarding glucose, protein and fat metabolism.

Secondary Outcome Measures
NameTimeMethod
Pathways of substrate metabolism.Five weeks

Description of the biochemical pathways underpinning the interplay between calorie restriction, SIRT1, STAT5 and the GH/IGF-I axis.

Trial Locations

Locations (1)

Aarhus University Hospital, Department of Endocrinology, MEA

🇩🇰

Aarhus, Denmark

© Copyright 2025. All Rights Reserved by MedPath